HK1058366A1 - Method for producing peptide salts, their use, andpharmaceutical preparations containing these pept ide salts. - Google Patents
Method for producing peptide salts, their use, andpharmaceutical preparations containing these pept ide salts.Info
- Publication number
- HK1058366A1 HK1058366A1 HK04101030A HK04101030A HK1058366A1 HK 1058366 A1 HK1058366 A1 HK 1058366A1 HK 04101030 A HK04101030 A HK 04101030A HK 04101030 A HK04101030 A HK 04101030A HK 1058366 A1 HK1058366 A1 HK 1058366A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- salts
- peptide
- andpharmaceutical
- preparations containing
- producing peptide
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 150000003839 salts Chemical class 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 3
- 239000003085 diluting agent Substances 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10040700A DE10040700A1 (de) | 2000-08-17 | 2000-08-17 | Salze von biologisch aktiven Peptiden, ihre Herstellung und Verwendung |
PCT/EP2001/009219 WO2002014347A2 (de) | 2000-08-17 | 2001-08-09 | Verfahren zur herstellung von peptidsalzen, deren verwendung und die peptidsalze enthaltende pharmazeutische zubereitungen |
CA002355573A CA2355573A1 (en) | 2000-08-17 | 2001-08-22 | Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1058366A1 true HK1058366A1 (en) | 2004-05-14 |
Family
ID=27805895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK04101030A HK1058366A1 (en) | 2000-08-17 | 2004-02-13 | Method for producing peptide salts, their use, andpharmaceutical preparations containing these pept ide salts. |
Country Status (30)
Country | Link |
---|---|
US (1) | US6780972B2 (xx) |
EP (1) | EP1309607B1 (xx) |
JP (1) | JP2004506647A (xx) |
CN (1) | CN1187369C (xx) |
AR (1) | AR030371A1 (xx) |
AT (1) | ATE280779T1 (xx) |
AU (2) | AU1043902A (xx) |
BG (1) | BG107612A (xx) |
BR (1) | BR0113296A (xx) |
CA (1) | CA2355573A1 (xx) |
CZ (1) | CZ2003688A3 (xx) |
DE (2) | DE10040700A1 (xx) |
DK (1) | DK1309607T3 (xx) |
EE (1) | EE200300065A (xx) |
ES (1) | ES2230371T3 (xx) |
HK (1) | HK1058366A1 (xx) |
HU (1) | HUP0300738A3 (xx) |
IL (1) | IL154150A0 (xx) |
MX (1) | MXPA03001448A (xx) |
NO (1) | NO20030618D0 (xx) |
NZ (1) | NZ524023A (xx) |
PL (1) | PL204496B1 (xx) |
PT (1) | PT1309607E (xx) |
RU (1) | RU2266296C2 (xx) |
SI (1) | SI1309607T1 (xx) |
SK (1) | SK3032003A3 (xx) |
TW (1) | TWI236910B (xx) |
UA (1) | UA74005C2 (xx) |
WO (1) | WO2002014347A2 (xx) |
ZA (1) | ZA200300777B (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6828415B2 (en) * | 1993-02-19 | 2004-12-07 | Zentaris Gmbh | Oligopeptide lyophilisate, their preparation and use |
US7098305B2 (en) * | 2001-09-06 | 2006-08-29 | Ardana Bioscience Limited | Sustained release of microcrystalline peptide suspensions |
EP1674082A1 (de) * | 2004-12-22 | 2006-06-28 | Zentaris GmbH | Verfahren zur Herstellung von sterilen Suspensionen oder Lyophilisaten schwerlöslicher basischer Peptidkomplexe, diese enthaltende pharmazeutische Formulierungen sowie ihre Verwendung als Arzneimittel |
RU2525661C2 (ru) * | 2012-11-15 | 2014-08-20 | Федеральное государственное бюджетное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" Российской академии медицинских наук (ФГБУ "НИИВС им. И.И. Мечникова" РАМН) | Способ получения высокотитражной антимикробной сыворотки для оценки антигенной активности противостафилококковых вакцин |
CN107056894B (zh) * | 2017-05-26 | 2021-07-20 | 济南康和医药科技有限公司 | 一种片段法固相合成醋酸加尼瑞克的方法 |
EP3590526A1 (en) * | 2018-07-05 | 2020-01-08 | Antev Limited | A lyophilization process and a teverelix-tfa lyophilizate obtained thereby |
CN114249800A (zh) * | 2020-09-22 | 2022-03-29 | 深圳市星银医药有限公司 | 一种双羟萘酸多肽药物的制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4431635A (en) * | 1979-06-13 | 1984-02-14 | Coy David Howard | LH-RH Antagonists |
DE3165535D1 (en) * | 1980-06-02 | 1984-09-20 | Andrew Victor Schally | Lh-rh antagonists |
US4800191A (en) * | 1987-07-17 | 1989-01-24 | Schally Andrew Victor | LHRH antagonists |
DE4305225A1 (de) * | 1993-02-19 | 1994-08-25 | Asta Medica Ag | Neues Herstellverfahren für Cetrorelix Lyophilisat |
EP0626170A3 (en) * | 1993-05-10 | 1996-03-27 | Sandoz Ltd | Stabilization of pharmacoligically active compounds in controlled release compositions. |
DE4342092B4 (de) * | 1993-12-09 | 2007-01-11 | Zentaris Gmbh | Langwirkende Injektionssuspension und Verfahren zur Herstellung |
CA2178592C (en) * | 1993-12-09 | 2009-07-28 | Jurgen Engel | Long-acting injection suspensions and a process for their preparation |
US6054432A (en) * | 1996-09-12 | 2000-04-25 | Asta Medica Aktiengesellschaft | Means for treating prostate hypertrophy and prostate cancer |
RU2230550C2 (ru) * | 1998-01-16 | 2004-06-20 | Такеда Кемикал Индастриз, Лтд. | Композиции длительного высвобождения, способ их получения и применение |
-
2000
- 2000-08-17 DE DE10040700A patent/DE10040700A1/de not_active Withdrawn
-
2001
- 2001-08-09 PT PT01978273T patent/PT1309607E/pt unknown
- 2001-08-09 SK SK303-2003A patent/SK3032003A3/sk not_active Application Discontinuation
- 2001-08-09 SI SI200130237T patent/SI1309607T1/xx unknown
- 2001-08-09 AU AU1043902A patent/AU1043902A/xx active Pending
- 2001-08-09 ES ES01978273T patent/ES2230371T3/es not_active Expired - Lifetime
- 2001-08-09 RU RU2003107560/04A patent/RU2266296C2/ru not_active IP Right Cessation
- 2001-08-09 CZ CZ2003688A patent/CZ2003688A3/cs unknown
- 2001-08-09 PL PL359495A patent/PL204496B1/pl not_active IP Right Cessation
- 2001-08-09 AT AT01978273T patent/ATE280779T1/de not_active IP Right Cessation
- 2001-08-09 AU AU2002210439A patent/AU2002210439B2/en not_active Ceased
- 2001-08-09 JP JP2002519484A patent/JP2004506647A/ja active Pending
- 2001-08-09 BR BR0113296-2A patent/BR0113296A/pt not_active IP Right Cessation
- 2001-08-09 CN CNB018142192A patent/CN1187369C/zh not_active Expired - Fee Related
- 2001-08-09 MX MXPA03001448A patent/MXPA03001448A/es active IP Right Grant
- 2001-08-09 NZ NZ524023A patent/NZ524023A/en unknown
- 2001-08-09 EP EP01978273A patent/EP1309607B1/de not_active Expired - Lifetime
- 2001-08-09 DK DK01978273T patent/DK1309607T3/da active
- 2001-08-09 HU HU0300738A patent/HUP0300738A3/hu unknown
- 2001-08-09 EE EEP200300065A patent/EE200300065A/xx unknown
- 2001-08-09 DE DE50104316T patent/DE50104316D1/de not_active Expired - Lifetime
- 2001-08-09 WO PCT/EP2001/009219 patent/WO2002014347A2/de active IP Right Grant
- 2001-08-09 IL IL15415001A patent/IL154150A0/xx not_active IP Right Cessation
- 2001-08-16 AR ARP010103935A patent/AR030371A1/es active IP Right Grant
- 2001-08-17 TW TW090120293A patent/TWI236910B/zh active
- 2001-08-22 CA CA002355573A patent/CA2355573A1/en not_active Abandoned
- 2001-08-24 US US09/939,532 patent/US6780972B2/en not_active Expired - Fee Related
- 2001-09-08 UA UA2003032260A patent/UA74005C2/uk unknown
-
2003
- 2003-01-29 ZA ZA200300777A patent/ZA200300777B/xx unknown
- 2003-02-07 NO NO20030618A patent/NO20030618D0/no unknown
- 2003-03-06 BG BG107612A patent/BG107612A/bg unknown
-
2004
- 2004-02-13 HK HK04101030A patent/HK1058366A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE328851T1 (de) | Magnesium-ammonium-phosphat-zemente, deren herstellung und verwendung | |
CO5700735A2 (es) | Proceso para la preparacion de 2-cianopirrolidinas n-sustituidas | |
NZ515781A (en) | Compositions and methods comprising morphine gluconate | |
HK1058366A1 (en) | Method for producing peptide salts, their use, andpharmaceutical preparations containing these pept ide salts. | |
CA2235642A1 (en) | Processes for preparing sildenafil | |
WO2000048477A8 (en) | Acidic solution of sparingly-soluble group iia complexes | |
ATE156466T1 (de) | Verfahren und mischung zur behandlung von elektrolichtbogenofenstaub | |
AU2001289849A1 (en) | Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate | |
AU2002346825A1 (en) | Method for preparing a mixed zinc and manganese oxide | |
NZ514653A (en) | Process for producing an amide compound by reacting a compound with an amino group with a polyaminocarboxylic acid anhydride | |
ATE261401T1 (de) | Verfahren zur industriellen verwendung von muschelschalen | |
WO2001049605A3 (fr) | Procede de preparation de borates de terre rare et utilisation des borates obtenus en luminescence | |
PL354173A1 (en) | Mixture for the treatment of waste materials | |
BR9911969A (pt) | Sal e processos para a preparação de um sal, para a preparação de acetato de n-terc-butilhidroxilamina, para o isolamento de acetato de n-terc- butilhidroxilamina, e para a purificação do acetato de n-terc- butilhidroxilamina | |
ZA99812B (en) | Process for preparing (R)-2-bromo-3-phenyl-propionic acid. | |
GB0008179D0 (en) | Chemical process | |
HUP0001861A2 (hu) | Eljárás kontrasztanyagok előállítására | |
MXPA05007696A (es) | Modificacion cristalina de un complejo de manganeso. | |
MXPA05006279A (es) | Proceso para la preparacion de pregnanos. | |
HK1061232A1 (en) | Method for producing n-substituted hydroxylamines and the salts thereof | |
UA67941C2 (en) | A method for ammonium regeneration from the filtering liquid of ammonium-soda production | |
AU5643301A (en) | Mutant strains capable of producing chemically diversified proteins by incorporation of non-conventional amino acids | |
RU2000117742A (ru) | Способ лечения язвенной болезни | |
UA42962A (uk) | Спосіб одержання нітрату стронцію з апатиту | |
MXPA03004239A (es) | Complejos de metal de acido 2-hidroxi-4-metiltiobutanoico para su uso como alimento para animales. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHPA | Change of a particular in the register (except of change of ownership) | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20100809 |